Truist Raises Price Target on Bristol-Myers Squibb to $65 From $62, Keeps Buy Rating
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Market Closed -
Other stock markets
|
Pre-market 07:39:16 am | |||
59.71 USD | +1.00% |
|
56.89 | -4.72% |
07:22am | Bristol-Myers Squibb's Q4 Non-GAAP Earnings Decline, Revenue Increases | MT |
07:18am | Bristol Myers forecasts 2025 revenue below estimates after strong quarter | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration